New Delhi, Sept. 18 -- scheduled medical device is regulated by the Central Government and price increase of only upto 10% in a year is permitted," said *Dr. Girdhar Gyani, Director General, Association of Healthcare Providers (India)* The Government has also retained powers to regulate prices of medical devices in extraordinary circumstances and in public interest; the price ceiling for knee implants, which are non-scheduled devices, was fixed by the Central Government in 2017 under para 19 of the Drug Price Control Order, 2013. AHPI therefore believes that attributing the difference between procurement prices and MRP to hospitals, or suggesting that such pricing reflects an understanding or collusion between hospitals and manufacturers, w...